Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type.
Corey J HayesRebecca A RaciborskiMatthew NowakMahip AcharyaEdward V NunesTheresa M WinhusenPublished in: Addiction (Abingdon, England) (2024)
Early discontinuation of buprenorphine, and probably extended-release naltrexone, appears to be associated with a greater probability of experiencing a fatal or non-fatal overdose among US veterans receiving medication for opioid use disorder (MOUD); methadone does not show the same association. There is no consistent set of characteristics among early discontinuers by MOUD type.
Keyphrases